CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 852886-853064 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/68a7101a90454172c91785d8c352f776a82df5d4","sourcedb":"CORD-19","sourceid":"68a7101a90454172c91785d8c352f776a82df5d4","text":"Currently licensed therapies for MS include forms of interferon beta as well as more specifically targeted agents directed at adhesion molecules and the antigen receptor complex.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T38261","span":{"begin":0,"end":178},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T38261","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"Epistemic_Statements","denotations":[{"id":"T1884","span":{"begin":0,"end":178},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T1884","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T99","span":{"begin":0,"end":178},"obj":"Sentence"}],"attributes":[{"subj":"T99","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T3606","span":{"begin":33,"end":35},"obj":"Body_part"}],"attributes":[{"id":"A3606","pred":"uberon_id","subj":"T3606","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"},{"subj":"T3606","pred":"source","obj":"CORD-19-PD-UBERON"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5355","span":{"begin":33,"end":35},"obj":"Disease"},{"id":"T87437","span":{"begin":33,"end":35},"obj":"Disease"}],"attributes":[{"id":"A5355","pred":"mondo_id","subj":"T5355","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A52300","pred":"mondo_id","subj":"T87437","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"subj":"T5355","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T87437","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93ec97","default":true},{"id":"Epistemic_Statements","color":"#ec93a8"},{"id":"CORD-19_Custom_license_subset","color":"#93c2ec"},{"id":"CORD-19-PD-UBERON","color":"#dcec93"},{"id":"CORD-19-PD-MONDO","color":"#e293ec"}]}]}}